Virtus Investment Advisers’s Day One Biopharmaceuticals DAWN Stock Holding History

Virtus Investment Advisers’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,990	Closed	-$2.17M	–	475
2026 Q1	$2.17M	Buy	100,990 +19,243	+24%	+$271K	0.6%	12
2025 Q4	$762K	Buy	81,747 +15,320	+23%	+$128K	0.21%	147
2025 Q3	$468K	Hold	66,427	–	–	0.13%	211
2025 Q2	$432K	Buy	66,427 +38,397	+137%	+$264K	0.15%	211
2025 Q1	$222K	Buy	+28,030	New	+$302K	0.06%	256

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's DAWN Position: Q2 2026 in Review

Virtus Investment Advisers sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 100,990 shares — an estimated $2.17M sold.

Virtus Investment Advisers first reported a position in DAWN in Q1 2025 and held it in 5 quarters. The position peaked at $2.17M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Virtus Investment Advisers reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtus Investment Advisers sold 100,990 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.17M.
Virtus Investment Advisers first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 5 quarters.
Virtus Investment Advisers's Day One Biopharmaceuticals position peaked at $2.17M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.